Graybug Vision, Inc.·Healthcare

Toronto, Ontario--(Newsfile Corp. - April 8, 2026) - Graycliff Exploration Limited (CSE: GRAY) (OTC Pink: GRYCF) (FSE: GE0) (the "Company" or "Graycliff") is pleased to announce that it closed its previously announced private placement (the "Offering"). The Company raised gross proceeds of $650,000 via the issuance of 5,416,308 common share units of the Company ("Units").

ATLANTA, April 07, 2026 (GLOBE NEWSWIRE) -- Gray Media, Inc. (NYSE: GTN) today announced that it will release its earnings results for the quarter ended March 31, 2026, on Thursday, May 7, 2026.

BlackRock's iShares Staked Ethereum Trust ETF (ETHB) offers Ethereum exposure with on-chain staking yield, launching as a strong alternative to existing options. ETHB's higher staking ratio and temporarily reduced 0.12% sponsor fee enhance its appeal for yield-focused, long-term investors. Despite structural advantages, ETHB's launch occurs in a risk-off environment, limiting near-term upside; both ETHB and ETHUSD are rated 'Hold' with cautious optimism.

Graybug Vision, Inc. (NASDAQ: GRAY - Get Free Report)'s share price rose 10% during trading on Monday. The company traded as high as $0.78 and last traded at $0.7270. Approximately 656,290 shares were traded during mid-day trading, an increase of 30,214% from the average daily volume of 2,165 shares. The stock had previously closed at

Toronto, Ontario--(Newsfile Corp. - March 6, 2026) - Graycliff Exploration Limited (CSE: GRAY) (OTC Pink: GRYCF) (FSE: GE0) (the "Company" or "Graycliff") is pleased to announce that it intends to complete a non-brokered private placement (the "Offering") of up to 5,000,000 units (each, a "Unit") at $0.12 per Unit, for gross proceeds of up to $600,000. Each Unit will be composed of one (1) common share (a "Share") of the Company and one half of one (1/2) common share purchase warrant (each whole warrant, a "Warrant"), each Warrant to be exercisable at $0.18 per Share for one year from issuance.

Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - Graycliff Exploration Limited (CSE: GRAY) (OTC Pink: GRYCF) (FSE: GE0) (the "Company" or "Graycliff") is pleased to announce that it has executed an arm's length asset purchase agreement (the "Agreement"), dated February 26, 2026, with Mona McKinnon (the "Vendor"), contemplating the acquisition (the "Acquisition") of certain geologic data, core, pulp and material related to the Company's Shakespeare Project (the "Assets") from the Vendor for 2,300,000 common shares of the Company (the "Consideration Shares") at a deemed issue price of $0.14 per share, such shares to be issued on closing to the Vendor or its nominee(s) set out in the Agreement. Upon issuance, the Consideration Shares will be subject to voluntary resale restrictions, expiring: 25% four months and a day after the closing date (the "Closing"); 25% six months after the Closing; 25% nine months after the Closing; and 25% twelve months after the Closing.
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.